BCL2 and leukemia: Secondly, HG3 cells are resistant to the treatment of drugs able to inhibit antiapoptotic Bcl-2 family members, such as ABT-737, due to the overexpression of Mcl-1, a downstream effector of activating AKT in CLL and other leukemia [20,27].